HSY Financial Statements & Analysis
Complete financial statements for HSY including income statement, balance sheet, and cash flow statement. Analyze HSY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
60
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
0.3% ↑
Net Income
19.3% ↑
Gross Margin
5.7% ↑
Operating Margin
12.8% ↑
Balance Sheet
Current Ratio
-1.2% ↓
Debt to Equity
-7.6% ↑
Asset Turnover
-7.8% ↓
Cash Flow
Operating Cash Flow
9.0% ↑
Net Cash Flow
630.5% ↑
Free Cash Flow
24.1% ↑
Cash Flow to Debt
2.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2023 | 2024 | Change | Impact |
---|---|---|---|---|
Revenue | 11.16B | 11.20B | 0.3% | |
Gross Profit | 5.00B | 5.30B | 6.1% | |
Operating Income | 2.56B | 2.90B | 13.2% | |
Net Income | 1.86B | 2.22B | 19.3% | |
EPS | 9.09 | 10.97 | 20.7% | |
EBITDA | 2.75B | 3.10B | 12.7% | |
Gross Margin | 44.76% | 47.32% | 5.7% | |
Operating Margin | 22.94% | 25.87% | 12.8% | |
Net Income Margin | 16.68% | 19.83% | 18.9% | |
R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 11.20B | 11.16B | 10.42B | 8.97B | 8.15B |
Gross Profit | 5.30B | 5.00B | 4.50B | 4.05B | 3.70B |
Operating Income | 2.90B | 2.56B | 2.26B | 2.04B | 1.78B |
Net Income | 2.22B | 1.86B | 1.64B | 1.48B | 1.28B |
EPS | 10.97 | 9.09 | 8 | 7.15 | 6.13 |
EBITDA | 3.10B | 2.75B | 2.44B | 2.24B | 1.94B |
Gross Margin | 47.32% | 44.76% | 43.18% | 45.13% | 45.42% |
Operating Margin | 25.87% | 22.94% | 21.70% | 22.78% | 21.87% |
Net Income Margin | 19.83% | 16.68% | 15.79% | 16.47% | 15.69% |
R&D Expenses | 0 | 0 | 0 | 0 | 0 |